The regulation and activation of lupus-associated B cells

被引:27
作者
Fields, ML [1 ]
Hondowicz, BD [1 ]
Wharton, GN [1 ]
Adair, BS [1 ]
Metzgar, MH [1 ]
Alexander, ST [1 ]
Caton, AJ [1 ]
Erikson, J [1 ]
机构
[1] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA
关键词
D O I
10.1111/j.0105-2896.2005.00238.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Anti-double-stranded DNA (anti-dsDNA) B cells are regulated in non-autoimmune mice. While some are deleted or undergo receptor editing, a population of anti-dsDNA (VH3H9/V lambda 1) B cells that emigrate into the periphery has also been identified. These cells have an altered phenotype relative to normal B cells in that they have a reduced lifespan, appear developmentally arrested, and localize primarily to the T/B-cell interface in the spleen. This phenotype may be the consequence of immature B cells encountering antigen in the absence of T-cell help. When provided with T-cell help, the anti-dsDNA B cells differentiate into antibody-forming cells. In the context of the autoimmune-prone lpr/lpr or gld/gld mutations, the VH3H9/V lambda 1 anti-dsDNA B cells populate the B-cell follicle and by 12 weeks of age produce serum autoantibodies. The early event of anti-dsDNA B-cell follicular entry, in the absence of autoantibody production, is dependent upon CD4(+) T cells. We hypothesize that control of autoantibody production in young autoimmune-prone mice may be regulated by the counterbalancing effect of T-regulatory (T-reg) cells. Consistent with this model, we have demonstrated that T-reg cells are able to prevent autoantibody production induced by T-cell help. Additional studies are aimed at investigating the mechanisms of this suppression as well as probing the impact of distinct forms of T-cell-dependent and -independent activation on anti-dsDNA B cells.
引用
收藏
页码:165 / 183
页数:19
相关论文
共 128 条
  • [1] Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation
    Allman, D
    Lindsley, RC
    DeMuth, W
    Rudd, K
    Shinton, SA
    Hardy, RR
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (12) : 6834 - 6840
  • [2] Interleukin 6 is required for the development of collagen-induced arthritis
    Alonzi, T
    Fattori, E
    Lazzaro, D
    Costa, P
    Probert, L
    Kollias, G
    De Benedetti, F
    Poli, V
    Ciliberto, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (04) : 461 - 468
  • [3] In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines
    Ansel, KM
    McHeyzer-Williams, LJ
    Ngo, VN
    McHeyzer-Williams, MG
    Cyster, JG
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (08) : 1123 - 1134
  • [4] Differential effect of neonatal thymectomy on systemic and organ-specific autoimmune disease
    Bagavant, H
    Thompson, C
    Ohno, K
    Setiady, Y
    Tung, KSK
    [J]. INTERNATIONAL IMMUNOLOGY, 2002, 14 (12) : 1397 - 1406
  • [5] CD4+ T cells from lupus-prone mice avoid antigen-specific tolerance induction in vivo
    Bouzahzah, F
    Jung, S
    Craft, J
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 170 (02) : 741 - 748
  • [6] GENESIS AND EVOLUTION OF ANTICHROMATIN AUTOANTIBODIES IN MURINE LUPUS IMPLICATES T-DEPENDENT IMMUNIZATION WITH SELF ANTIGEN
    BURLINGAME, RW
    RUBIN, RL
    BALDERAS, RS
    THEOFILOPOULOS, AN
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04) : 1687 - 1696
  • [7] Activation of diverse repertoires of autoreactive T cells enhances the loss of anti-dsDNA B cell tolerance
    Busser, BW
    Adalr, BS
    Erikson, J
    Laufer, TM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (09) : 1361 - 1371
  • [8] B cells and professional APCs recruit regulatory T cells via CCL4
    Bystry, RS
    Aluvihare, V
    Welch, KA
    Kallikourdis, M
    Betz, AG
    [J]. NATURE IMMUNOLOGY, 2001, 2 (12) : 1126 - 1132
  • [9] Peripheral B-cell maturation: the intersection of selection and homeostasis
    Cancro, MP
    [J]. IMMUNOLOGICAL REVIEWS, 2004, 197 : 89 - 101
  • [10] Cassese G, 2001, EUR J IMMUNOL, V31, P2726, DOI 10.1002/1521-4141(200109)31:9<2726::AID-IMMU2726>3.0.CO